|
|
2002 Region C DMEPOS Fee Schedule
2002 Region C DMEPOS Fee Schedule Oral Anti-Cancer Drugs
DRUG NAME | STRENGTH | 01/01/2002
PER TABLET FEE |
| Busulfan | 2 mg | $1.91 |
| Capecitabine | 150 mg | $2.43 |
| Capecitabine | 500 mg | $8.11 |
| Cyclophosphamide | 25 mg | $1.98 |
| Cyclophosphamide | 50 mg | $3.64 |
| Etoposide | 50 mg | $52.43 |
| Melphalan | 2 mg | $2.29 |
| Methotrexate | 2.5 mg | $2.92 |
| Temozolomide | 5 mg | $6.17 |
| Temozolomide | 20 mg | $24.68 |
| Temozolomide | 100 mg | $123.40 |
| Temozolomide | 250 mg | $308.49 |
NOTE: The “DMEPOS Drug Update” is revised quarterly. Currently, the drugs listed above meet the requirements for coverage under OBRA ‘93. Inclusion or exclusion of an allowable amount for an item or service does not imply Medicare coverage.
Unlike other drugs billable to the DMERC, these oral anti-cancer drugs are not submitted with HPCPS codes. Oral anti-cancer drugs are billed using the National Drug Code (NDC) number.
 Copyright  2025, Palmetto GBA. All Rights Reserved. |
|